Results 201 to 210 of about 302,633 (354)

Trends in incidence of esophageal squamous cell carcinoma in the United States between 2001–2021: a United States Cancer Statistics database study

Yazan Abboud, Anila Vasireddy, Jennifer M. Kolb, Cadman L. Leggett, Prasad G. Iyer, Srinivas Gaddam, Amrit K. Kamboj   +6 more
openalex   +1 more source

Case Report: Esophageal cancer under comprehensive treatment strategy—application and clinical outcome analysis of combined immunotherapy, targeted therapy, and low-dose radiotherapy [PDF]

Yanling Yuan, Xingxi Pan, Lihua Tong, Wanming He, Wen‐Bin Yang   +4 more
openalex   +1 more source

Case‐Based Immunology: B Cells and Systemic Sclerosis Interstitial Lung Disease

Arthritis &Rheumatology, EarlyView.
Interstitial lung disease (ILD) is an important complication of systemic sclerosis (SSc), with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to US Food and Drug Administration–approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of ILDs of other systemic autoimmune
Nina Goldman, Voon Ong, Christopher P. Denton   +2 more
wiley   +1 more source

Knowledge, attitudes, and practices toward esophageal cancer screening and early diagnosis and treatment among family members of esophageal cancer patients: A cross-sectional study. [PDF]

Sci Rep
Yu H, Qiu K, Yu D, Liu Y, Xu S.
europepmc   +1 more source

Dysphagia after Surgery for Esophageal Cancer

, 2010
Masahiko Yano, Masaaki Motoori, K Tanaka, Kanta Kishi, Isao Miyashiro, S. Noura, Masayuki Ohue, Taro Yamada, Hiroaki Ohigashi, Osamu Ishikawa   +9 more
openalex   +1 more source

Plasma Proteomics Identifies TAOK3 as a Potential Biomarker of Rheumatoid Arthritis Activity and a Novel Therapeutic Target

Arthritis &Rheumatology, Accepted Article.
Objective Bone destruction associated with active rheumatoid arthritis (RA) remains a major therapeutic challenge, with a lack of reliable molecular markers reflecting bone injury. This study aims to identify novel biomarkers linked to bone destruction in active RA through proteomic analysis, providing new strategies for precise monitoring and targeted
Pengfei Xin, Wenzhen Li, Xinyu A, Jun Shen, Xiaohui Meng, Yanqin Bian, Haihui Han, Zheng Xiang, Lei Ran, Songtao Sun, Jun Xie, Tao Yue, Qi Zhu, Xiaoming Zhang, Lu Xie, Lianbo Xiao   +15 more
wiley   +1 more source

Construction of a preoperative prehabilitation program for elderly esophageal cancer patients. [PDF]

Front Oncol
Chen X, Zhou K, Cai F, Liu Z, Luo C, Shao X.   +5 more
europepmc   +1 more source

Clinical results of multimodality therapy for esophageal cancer with distant metastasis [PDF]

, 2018
Masakuni Sakaguchi, Toshiya Maebayashi, Takuya Aizawa, Naoya Ishibashi, Tsutomu Saito   +4 more
openalex   +1 more source

Long‐Term Outcomes of Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for Systemic Sclerosis Patients with Impaired Cardiac Function

Arthritis &Rheumatology, Accepted Article.
Objective High intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced SSc. The role of reduced intensity conditioning (RIC) prior to AHSCT in this population remains unclear. We conducted this study to determine the long‐term outcomes of RIC AHSCT in SSc patients with cardiac ...
Yonatan Lean, Carrie Richardson, Anthony Esposito, Katy Bedjeti, George E. Georges   +4 more
wiley   +1 more source

A multimodal synergistic model for personalized neoadjuvant immunochemotherapy in esophageal cancer. [PDF]

Cell Rep Med
Zhao Z, Chen D, Wei X, Li S, Zhang X, Lin W, Zheng X, Zheng K, Wu S, Wen X, Zhang B, Zheng Y, Chen S, Xie C, Li S, Xie D, Wang R, Xing W, Zhou J, Cai M.   +19 more
europepmc   +1 more source